interviewingadvisoryOncologySmall molecule
Phase 2 Oncology PI Consultant
Helix Bio· posted 1 week ago
About this engagement
We're standing up a Phase 2 melanoma adaptive trial and need a senior PI consultant to lead protocol design, run quarterly interim analyses, and represent us in the FDA Type C meeting in Q3. CDMO experience strongly preferred — we'll be running comparative formulation work in parallel.
Required capabilities
Phase 2 oncologyCDMO experienceAdaptive trial designFDA Type C meetings
Nice to have
Melanoma specialtyBayesian interim analyses
About the sponsor
Helix Bio is a biotech working in Oncology. They've engaged 4 advisors via LynQX in the last 12 months with a 92% renewal rate.
This engagement is part of campaign: Helix Bio · Phase 2 Oncology Team Build.
Similar projects in Oncology
Author CMC sections for Q4 BLA submission. 6mo, 16 hrs/mo.
16 hrs/mo · 6mo
Boston, MA · remote OK
$500–$750/hr
apply by Jun 15, 2026
Module 3 authorshipBLA prepPre-BLA meeting
11 applicantsView & apply
Quarterly SAB role, focus on Phase 1/2 immuno-oncology pipeline.
4 hrs/mo · 24mo
Remote · remote OK
$5k retainer + $1.5k/meeting
apply by Jun 10, 2026
Phase 1/2 immuno-oncologySAB experience
18 applicantsView & apply